Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2014

View Archived Issues

ApoE2 gene delivery reduces amyloid burden in the brain of transgenic mice

Genetic diversity affects susceptibility to Ebola virus infection

IOmet Pharma describes novel small-molecule GLUT-1 inhibitors for cancer

BioCryst reports data for BCX-4430 in model of Ebola virus infection

Elios Therapeutics' personalized cancer vaccine cleared for phase IIb testing

Cancer Research UK, CRT and Amgen to study AMG-319 in solid tumors

Roivant Neurosciences acquires SB-742457 from GlaxoSmithKline

Amarantus BioScience's Alzheimer's disease diagnostic available for use in clinical trials

Phylogica and Genentech enter antibacterial discovery collaboration

ADDC and AstraZeneca to support five high-throughput screening proposals

Endo Pharmaceuticals and BioDelivery Sciences submit NDA for Buprenorphine Buccal Film

BioCryst receives orphan drug designation for BCX-4161 for hereditary angioedema

Amarantus receives FDA orphan drug designation for MANF for retinitis pigmentosa

FDA approves supplemental BLA for Gazyva

Takeda submits NDA in Japan for glatiramer acetate

Takecab approved for the treatment of acid-related diseases in Japan

Chugai Pharmaceutical obtains approval of vemurafenib in Japan

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Vimizim approved in Japan for Morquio A syndrome

European approval for Xpert HIV-1 Viral Load test

Chiesi Farmaceutici patents MAPK 14 inhibitors

CSIR divulges silicon-containing antituberculosis pyrroles

Merck KGaA reports discovery of MST1R inhibitor

FDA approves use of Kalydeco for R117H mutation in cystic fibrosis

Data presented on a new chimeric antigen receptor targeting cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.